WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 206151
CAS#: 1402608-02-9 (free base)
Description: BAY1125976 is an orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B) isoforms 1 and 2 (AKT1/2) with potential antineoplastic activity. AKT1/2 inhibitor BAY1125976 selectively binds to and inhibits the phosphorylation and activity of AKT1/2 in a non-ATP competitive manner, which may result in the inhibition of the phosphatidylinositol 3 (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway. This may lead to both the reduction of cell proliferation and the induction of cell apoptosis in AKT-overexpressing tumor cells. The AKT signaling pathway is often deregulated in cancer and is associated with tumor cell proliferation, survival and migration.
MedKoo Cat#: 206151
Name: BAY1125976 HCl
CAS#: 1402608-02-9 (free base)
Chemical Formula: C23H23Cl2N5O
Exact Mass:
Molecular Weight: 456.371
Elemental Analysis: C, 60.53; H, 5.08; Cl, 15.54; N, 15.35; O, 3.51
Related CAS #: 1402608-02-9 (free base) CAS# oif its HCl is unknown
Synonym: BAY1125976; BAY 1125976; BAY-1125976; BAY1125976 HCl; BAY1125976 dihydrochloride; BAY1125976 hydrochloride;
IUPAC/Chemical Name: Imidazo[1,2-b]pyridazine-6-carboxamide, 2-[4-(1-aminocyclobutyl)phenyl]-3-phenyl- dihydrochloride
InChi Key: FQADVAXTTOAHES-UHFFFAOYSA-N
InChi Code: InChI=1S/C23H21N5O.2ClH/c24-22(29)18-11-12-19-26-20(21(28(19)27-18)16-5-2-1-3-6-16)15-7-9-17(10-8-15)23(25)13-4-14-23;;/h1-3,5-12H,4,13-14,25H2,(H2,24,29);2*1H
SMILES Code: O=C(C1=NN2C(C=C1)=NC(C3=CC=C(C4(N)CCC4)C=C3)=C2C5=CC=CC=C5)N.[H]Cl.[H]Cl
